NovoCure Amends 2024 Omnibus Incentive Plan for Employee Compensation
NovoCure Limited filed an amended and restated 2024 Omnibus Incentive Plan to enhance shareholder value through employee and director incentive awards. The plan framework enables the company to attract and retain talent through equity-based compensation structures.
View filing at SEC.gov →